We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan Sued Over Blood Pressure Drug

Law360 (June 4, 2008, 12:00 AM EDT) -- In a move to protect the market for the hypertension drug Azor, Japanese pharmaceutical company Daiichi Sankyo Co. Ltd. on Tuesday hit Mylan Inc. with a patent infringement suit.

Daiichi Sankyo and its U.S.-based unit Daiichi Sankyo Inc. lodged the lawsuit in the U.S. District Court for the District of New Jersey against Mylan and its majority-owned subsidiary Matrix Laboratories Inc.

The Japanese company was responding to an abbreviated new drug application Matrix filed in early 2008 seeking the U.S. Food and Drug Administration's approval to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.